NCT01960634View on ClinicalTrials.gov

Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma

CompletedOBSERVATIONAL
Enrollment

58

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Stage IV Skin Melanoma
Trial Locations (13)

28034

Hospital Ramón y Cajal, Madrid

29603

Hospital Costa del SOl, Marbella

35001

Hospital Insular de Gran Canaria, Las Palmas de Gran Canaria

39008

Hospital Marques de Valdecilla, Santander

46009

Fundación Instituto Valenciano de Oncología, Valencia

50009

Hospital Miguel Servet, Zaragoza

06080

Hospital Infanta Cristina, Madrid

08916

Hospital Germans Trias i Pujol, Badalona

08003

Hospital del Mar, Barcelona

08028

Hospital Universitario Quirón Dexeus, Barcelona

08035

Hospital Vall d'Hebron, Barcelona

08041

Hospital de la Santa Creu i Sant Pau, Barcelona

Unknown

Hospital Virgen de la Salud, Toledo

All Listed Sponsors
lead

Grupo Español Multidisciplinar de Melanoma

OTHER

NCT01960634 - Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma | Biotech Hunter | Biotech Hunter